SCHEMBL4532200

SCHEMBL4532200

CO[Si](CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCBr)(OC)OC

nearest known ligand 0.42

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4516206 1.00 LMNA (0.42) LMNA
SCHEMBL3792773 1.00 LMNA (0.42) LMNA
SCHEMBL4518164 1.00 LMNA (0.42) LMNA
SCHEMBL4517667 1.00 LMNA (0.42) LMNA
SCHEMBL4524440 1.00 LMNA (0.42) LMNA
SCHEMBL4535999 1.00 LMNA (0.42) LMNA
SCHEMBL4532614 1.00 LMNA (0.42) LMNA
SCHEMBL522152 1.00 LMNA (0.42) LMNA
SCHEMBL4533362 1.00 LMNA (0.42) LMNA
SCHEMBL4524102 1.00 LMNA (0.42) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090123516-A1 DRUG DELIVERY FROM IMPLANTS USING SELF-ASSEMBLED MONOLAYERS-THERAPEUTIC SAMS THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2009-05-14 US disclosed
WO-2007019478-A2 DRUG DELIVERY FROM IMPLANTS USING SELF-ASSEMBLED MONOLAYERS - THERAPEUTIC SAMS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2007-02-15 WO disclosed